Internal Medicine, Hematology & Oncology · Pensacola, FL
NPI
1356474548
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1545 Airport Blvd Ste 2000
Pensacola, FL, 32504
Phone (850) 416-6933
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,466 services
Medicare patients, 2024
551
Average age 73
Drug cost, 2024
$4.4M
2,379 prescriptions
Company payments, 2025
$667
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dany Elsayah was code 99214 (office e&m - established), 756 times for 281 patients. In total Dany Elsayah billed 1,466 services in 13 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 756 | 281 | $72.40 | $55K |
| 99213 Office E&M - Established | Office | 396 | 282 | $47.59 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 107 | 38 | $61.83 | $6,616 |
| 99222 Hospital E&M - Initial | Facility | 47 | 44 | $105.61 | $4,964 |
| 99204 Office E&M - New | Office | 38 | 38 | $101.31 | $3,850 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 16 | $95.47 | $3,150 |
| 99203 Office E&M - New | Office | 21 | 21 | $60.32 | $1,267 |
| 99238 Hospital Discharge Management | Facility | 19 | 16 | $65.04 | $1,236 |
| 99212 Office E&M - Established | Office | 18 | 17 | $27.21 | $490 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $138.91 | $1,667 |
By year: 2022 $109K for 1,582 services; 2023 $116K for 1,875 services; 2024 $98K for 1,466 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dany Elsayah prescribed most often to Medicare patients was Anastrozole, with 150 prescriptions and refills. In total Dany Elsayah wrote 2,379 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 150 | 378 | 43 | $2,990 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 120 | 120 | 36 | $4,293 |
| Letrozole Generic | 80 | 154 | 22 | $1,698 |
| Gabapentin Generic | 75 | 83 | 15 | $1,151 |
| Ondansetron Hcl Generic | 71 | 71 | 29 | $1,126 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 59 | 59 | 15 | $2,052 |
| Prednisone Generic | 53 | 64 | 22 | $246 |
| Hydroxyurea Generic | 52 | 112 | 12 | $1,228 |
| Oxycodone Hcl Generic | 52 | 52 | 23 | $1,448 |
| Ondansetron Odt Ondansetron | 49 | 49 | 23 | $1,257 |
| Alprazolam Generic | 47 | 47 | Under 11 | $475 |
| Trazodone Hcl Generic | 45 | 86 | 11 | $244 |
| Xarelto Rivaroxaban | 43 | 76 | Under 11 | $43K |
| Brukinsa Zanubrutinib | 43 | 43 | Under 11 | $610K |
| Eliquis Apixaban | 41 | 53 | Under 11 | $29K |
Brand drugs: 442 claims; generic drugs: 1,937 claims; opioid claims: 361.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dany Elsayah $667 ($667 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novartis Pharmaceuticals Corporation with $292.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 7 | $292 |
| Celgene Corporation BMY | 5 | $113 |
| Abbvie Inc. ABBV | 3 | $63.98 |
| Galvanize Therapeutics, Inc | 1 | $58.41 |
| GlaxoSmithKline, LLC. GSK | 2 | $38.62 |
| Pfizer Inc. PFE | 2 | $29.37 |
| Aveo Pharmaceuticals, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $18.78 |
| Eisai Inc. 4523.T | 1 | $16.79 |
| Array Biopharma Inc PFE | 1 | $13.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.